4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Omeros Corporation (OMER) operates in the Biotechnology industry and is headquartered in Seattle, United States with about 175 employees. Its market capitalization is roughly $701 million. In the fiscal year ended 2025-12-31, OMER reported $0M in revenue and ($3M) in net income.
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
Interactive charts & full statements → Open the OMER valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | — | $0M |
| Operating Income (EBIT) | ($123M) | ($167M) | ($164M) | ($163M) | — |
| Net Income | ($3M) | ($157M) | ($118M) | $47M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $10M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $9M | — | — | — | $0M | — |
| Operating Income (EBIT) | ($17M) | ($29M) | ($26M) | ($32M) | ($35M) | — |
| Net Income | $56M | $86M | ($31M) | ($25M) | ($34M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $326M | $277M | $378M | $591M | — |
| Total Liabilities | $447M | $460M | $403M | $505M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OMER viewer.
About TickerBase · Data methodology & sources